fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Search » Marksans Pharma Ltd

Marksans Pharma Ltd

Updated on November 22, 2020

Stock/Share Code - MARKSANS

Marksans Pharma is engaged in Business of Formulation of pharmaceutical products.

Below is the details of MARKSANS Marksans Pharma Ltd

Market Cap₹1,866 Cr.
Current Price ₹58.95 as on 27 Nov 20
52 Week High / Low Price₹57.1 / ₹9.85
Face Value₹1
Stock P/E34.37
Book Value₹12.35
Dividend Yield0.22 %
ROCE11.39 %
ROE7.76 %
Sales Growth (3yrs)26.16 %
SectorPharmaceuticals
IndustryPharmaceuticals - Indian - Bulk Drugs
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Company has reduced debt. Company is virtually debt free.
Cons: Stock is trading at 3.70 times its book value Company has a low return on equity of 6.90% for last 3 years.

Marksans Pharma Ltd Price Chart

Marksans Pharma Ltd Price Chart

Marksans Pharma Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Divi's Lab. ₹140.9 51.94 ₹82,900.53 Cr. 0.51 ₹492.06 Cr. 80.61 48.81 1730.47 25.19
2. Lupin ₹891.8 ₹42,032.3 Cr. 0.65 ₹106.9 Cr. -64.73 -9.02 3527.86 9.23
3. Jubilant Life ₹723 13.50 ₹12,477.17 Cr. 0.64 ₹260.49 Cr. 248.25 0.24 2391.41 15.46
4. Granules India ₹412.55 22.60 ₹7,765.53 Cr. 0.32 ₹111.45 Cr. 33.89 23.57 735.60 17.15
5. Aarti Drugs ₹715.05 31.46 ₹6,319.31 Cr. 0.07 ₹85.45 Cr. 280.62 34.34 544.67 20.87
6. Shilpa Medicare ₹471.35 23.66 ₹4,289.13 Cr. 0.21 ₹86.31 Cr. 159.66 38.43 222.86 12.62
7. Sequent Scien. ₹155.65 40.58 ₹3,221.37 Cr. 0.15 ₹20.92 Cr. 82.55 11.60 310.27 12.29
8. Marksans Pharma 34.37 ₹1,866.47 Cr. 0.22 ₹22.06 Cr. 289.75 68.75 155.96 11.39

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Marksans Pharma Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020
Sales -758087931151259192101117114156
YOY Sales Growth %36%24%61%78%52%56%5%-1%-12%-7%25%69%
Expenses -69697676971088882889795127
Material Cost %62.18%58.12%56.37%50.14%54.64%59.02%58.26%59.63%61.57%55.11%54.12%49.97%
Employee Cost %14.72%14.57%12.83%12.19%10.19%10.06%11.74%12.80%11.81%10.64%10.86%7.87%
Operating Profit6121117181731013201829
OPM %8%14%12%18%16%14%4%11%13%17%16%19%
Other Income-0-0033010280-00
Interest213221222121
Depreciation333222233333
Profit before tax1861717149816161325
Tax %-138%27%24%17%25%16%36%28%24%19%44%11%
Net Profit164141212661213722
EPS in Rs0.030.140.110.340.300.290.140.140.290.320.180.54
NotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotes

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020TTM
Sales -200200155155192315406358216295424433487
Sales Growth %-15.62%0.02%-22.48%-0.07%24.39%63.78%28.78%-11.70%-39.73%36.52%43.95%2.18%
Expenses -179176235272148231290254191266361362407
Material Cost %67%73%69%57%53%54%54%50%52%57%56%56%
Manufacturing Cost %5%4%4%7%8%5%4%5%7%5%4%0%
Employee Cost %6%5%7%9%8%7%6%7%18%16%11%11%
Other Cost %12%6%71%104%8%8%8%9%12%12%14%16%
Operating Profit2024-81-11844841161042429637180
OPM %10%12%-52%-76%23%27%29%29%11%10%15%16%17%
Other Income71-792433977808
Interest15153949101513648776
Depreciation1010151899915151291212
Profit before tax21-213-183306397921217565370
Tax %79%54%-2%1%-34%12%31%22%3%25%22%28%
Net Profit00-218-181405667711212443854
EPS in Rs1.031.421.611.720.190.301.070.931.33
Dividend Payout %-0%-0%-0%-0%-0%7%7%7%18%16%5%11%

Compounded Sales Growth

  • 10 Years:: 8.06%
  • 5 Years:: 1.34%
  • 3 Years:: 26.16%
  • TTM:: 15.06%

Compounded Profit Growth

  • 10 Years:: 60.22%
  • 5 Years:: -10.80%
  • 3 Years:: 48.69%
  • TTM:: 53.42%

Return on Equity

  • 10 Years:: 27.89%
  • 5 Years:: -12.91%
  • 3 Years:: 4.33%
  • 1 Year:: 234.43%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Share Capital -505050505252535341414141
Preference Capital13.5013.5013.5013.5013.5013.5012.5012.500.000.000.00
Equity Capital36.7836.7836.7836.7838.5338.5340.9340.9340.9340.9340.9340.93
Reserves109125-92-24058108305369378388430465
Borrowings31935310310091895041736778-0
Other Liabilities -62603593451231411328354616488
Trade Payables373530293040453121343751
Other liability items252532931693100875233282738
Total Liabilities526575407243310376527534546557612594
Fixed Assets -27929418577736790979488103115
Gross Block335360213123128130162184196202225
Accumulated Depreciation5666284655637287102114122
CWIP-0-0-0-0-0-0-0-00-0-0-0
Investments68786824686868231234236236236
Other Assets -180204154142170242369205217233273243
Inventories988340405156514429427075
Trade receivables5167727491112125133155169178162
Cash Equivalents1333261803316833123
Loans n Advances1923146363927253121232
Other asset items-2-214-91-1-00011
Total Assets526575407243310376527534546557612594

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Cash from Operating Activity -8912-68-6195411265-141620118
Profit from operations1418-106-63457811410024376872
Receivables5-16-5-2-17-21-12-9-21-14-916
Inventory251543-0-11-45714-13-28-4
Payables-9-2-3-192322-15-102424
Loans Advances56-455-16-141410000
Other WC items0000-0000-219-220
Working capital changes77-6402-36-1629-15-38-16-3557
Direct taxes-20-1-10-8-31-200-5-13-10
Cash from Investing Activity --142-342641-48-2-29-177-8-8-20-24
Fixed assets purchased-83.62-25.140.00-4.56-4.91-2.61-32.23-22.20-11.78-5.86-23.45-24.18
Fixed assets sold0.000.0014.380.000.000.000.000.000.000.000.000.00
Investments purchased-64.86-10.060.0044.10-44.100.000.00-163.82-2.85-1.780.000.00
Investments sold0.000.0010.000.000.000.000.000.000.000.000.000.00
Interest received6.921.311.681.930.770.603.092.300.150.040.030.08
Dividends received0.000.000.000.000.000.000.006.386.690.003.620.00
Other investing items0.000.000.000.000.000.000.000.000.120.05-0.390.00
Cash from Financing Activity -2242361122-1951-5221-101-92
Proceeds from shares170004013100000
Proceeds from borrowings155849000000000
Repayment of borrowings-2-240-15-229000000-77
Interest paid fin-8-8-13-9-7-7-6-3-4-8-7-7
Dividends paid00000-6-7-7-6-2-2-2
Financial liabilities00000000000-5
Other financing items016035254-7-67-4231010-1
Net Cash Flow-3020-6-9-1733134-164-1-212

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Ratios

Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
ROCE %4%3%-32%71%35%33%22%3%5%12%11%
Debtor Days93123170175174130112136262209153136
Inventory Turnover1.251.671.812.282.343.294.243.923.274.934.343.35

Announcements & News

Recent Announcements

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at Fincash.com.
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Marksans Pharma Ltd & Get More Returns than Bank Deposit

Disclaimer:
All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.